Skip to main content
Erschienen in: Journal of Endocrinological Investigation 10/2023

04.04.2023 | Original Article

Hashimoto’s thyroiditis and renal transplant rejection

verfasst von: B. Sigman, D. F. Linder, J. L. Waller, W. B. Bollag, S. L. Baer, S. Tran, M. Kheda, L. Young, A. Mohammed, C. M. Isales, B. Siddiqui

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hashimoto’s thyroiditis (HT) is a common autoimmune thyroid disorder that can disrupt thyroid function and homeostasis. As HT results from a dysregulated immune system, we hypothesized that these patients might be more susceptible to transplant failure; however, literature on this association is limited. The purpose of this study is to examine the association of HT with the risk of renal transplant failure.

Methods

We utilized the United States Renal Database System dataset collected from 2005 to 2014 and compared the time from first renal transplant to transplant failure in end-stage renal disease (ESRD) patients with a HT diagnosis to ESRD patients without a HT diagnosis that underwent renal transplant.

Results

A total of 144 ESRD patients had International Classification of Disease-9 claim codes for HT prior to renal transplant, amongst a total cohort of 90,301 renal transplant patients aged 18–100 and meeting criteria. Patients with HT were significantly more likely to be female, white, and to have a diagnosis of cytomegalovirus compared to patients without. ESRD patients with a HT diagnosis that underwent renal transplant had a significantly increased risk of renal transplant failure compared to those ESRD renal transplant patients without an HT diagnosis. There was a significantly increased adjusted hazard ratio for graft failure in patients with a HT diagnosis compared to those without.

Conclusion

Thyroid health and HT may play a significant role in the development of the increased risk of renal transplant failure observed in this study. Additional studies are needed to investigate the underlying mechanisms for this association.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lo JC, Chertow GM, Go AS, Hsu C-Y (2005) Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 67:1047–1052CrossRefPubMed Lo JC, Chertow GM, Go AS, Hsu C-Y (2005) Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 67:1047–1052CrossRefPubMed
3.
Zurück zum Zitat Papalia T, Greco R, Lofaro D, Mollica A, Bonofiglio R (2011) Thyroid status and kidney transplantation outcomes. Transplant Proc 43:1042–1044CrossRefPubMed Papalia T, Greco R, Lofaro D, Mollica A, Bonofiglio R (2011) Thyroid status and kidney transplantation outcomes. Transplant Proc 43:1042–1044CrossRefPubMed
4.
Zurück zum Zitat Łebkowska U, Małyszko J, Łebkowski WJ, Walecki J, Myśliwiec M (2003) Is there any relation between thyroid gland function and kidney transplant function? Transplant Proc 35:2222–2223CrossRefPubMed Łebkowska U, Małyszko J, Łebkowski WJ, Walecki J, Myśliwiec M (2003) Is there any relation between thyroid gland function and kidney transplant function? Transplant Proc 35:2222–2223CrossRefPubMed
5.
Zurück zum Zitat Rydzewska M, Jaromin M, Pasierowska IE, Stożek K, Bossowski A (2018) Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res 11:2CrossRefPubMedPubMedCentral Rydzewska M, Jaromin M, Pasierowska IE, Stożek K, Bossowski A (2018) Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res 11:2CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roliński J (2015) Immune disorders in Hashimoto’s thyroiditis: what do we know so far? J Immunol Res 2015:979167CrossRefPubMedPubMedCentral Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roliński J (2015) Immune disorders in Hashimoto’s thyroiditis: what do we know so far? J Immunol Res 2015:979167CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Chiovato L et al (1993) Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77:1700–1705PubMed Chiovato L et al (1993) Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77:1700–1705PubMed
8.
11.
Zurück zum Zitat Haubitz M, Kliem V, Koch KM, Nashan B, Schlitt HJ, Pichlmayr R, Brunkhorst R (1997) Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients. Clin Transplant 63(9):1251–1257CrossRef Haubitz M, Kliem V, Koch KM, Nashan B, Schlitt HJ, Pichlmayr R, Brunkhorst R (1997) Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients. Clin Transplant 63(9):1251–1257CrossRef
12.
Zurück zum Zitat Barbouch S et al (2017) Outcome of renal transplant in recipients with vasculitis. Exp Clin Transplant 15:93–96PubMed Barbouch S et al (2017) Outcome of renal transplant in recipients with vasculitis. Exp Clin Transplant 15:93–96PubMed
14.
Zurück zum Zitat Boelaert K et al (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123(183):e1-183.e9 Boelaert K et al (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123(183):e1-183.e9
15.
Zurück zum Zitat Fallahi P et al (2016) The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun Rev 15:1125–1128CrossRefPubMed Fallahi P et al (2016) The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun Rev 15:1125–1128CrossRefPubMed
16.
Zurück zum Zitat Bliddal S, Nielsen CH, Feldt-Rasmussen U (2017) Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity. F1000Res 6:1776CrossRefPubMedPubMedCentral Bliddal S, Nielsen CH, Feldt-Rasmussen U (2017) Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity. F1000Res 6:1776CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619CrossRefPubMed
18.
Zurück zum Zitat Sundararajan V et al (2004) New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 57:1288–1294CrossRefPubMed Sundararajan V et al (2004) New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 57:1288–1294CrossRefPubMed
19.
Zurück zum Zitat Vadivel N, Tullius SG, Chandraker A (2007) Chronic allograft nephropathy. Semin Nephrol 27:414–429CrossRefPubMed Vadivel N, Tullius SG, Chandraker A (2007) Chronic allograft nephropathy. Semin Nephrol 27:414–429CrossRefPubMed
20.
Zurück zum Zitat Dimény E, Wahlberg J, Lithell H, Fellström B (1995) Hyperlipidaemia in renal transplantation–risk factor for long-term graft outcome. Eur J Clin Invest 25:574–583CrossRefPubMed Dimény E, Wahlberg J, Lithell H, Fellström B (1995) Hyperlipidaemia in renal transplantation–risk factor for long-term graft outcome. Eur J Clin Invest 25:574–583CrossRefPubMed
21.
Zurück zum Zitat Winkelmayer WC et al (2005) Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol 16:255–260CrossRefPubMed Winkelmayer WC et al (2005) Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol 16:255–260CrossRefPubMed
22.
23.
Zurück zum Zitat Bohl DL, Brennan DC (2007) BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2:S36–S46CrossRefPubMed Bohl DL, Brennan DC (2007) BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2:S36–S46CrossRefPubMed
24.
Zurück zum Zitat Wang L, Wang F-S, Gershwin ME (2015) Human autoimmune diseases: a comprehensive update. J Intern Med 278:369–395CrossRefPubMed Wang L, Wang F-S, Gershwin ME (2015) Human autoimmune diseases: a comprehensive update. J Intern Med 278:369–395CrossRefPubMed
25.
Zurück zum Zitat Lahner E et al (2020) Thyro-entero-gastric autoimmunity: pathophysiology and implications for patient management. Best Pract Res Clin Endocrinol Metab 34:101373CrossRefPubMed Lahner E et al (2020) Thyro-entero-gastric autoimmunity: pathophysiology and implications for patient management. Best Pract Res Clin Endocrinol Metab 34:101373CrossRefPubMed
27.
Zurück zum Zitat Hollowell JG et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499CrossRefPubMed Hollowell JG et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499CrossRefPubMed
Metadaten
Titel
Hashimoto’s thyroiditis and renal transplant rejection
verfasst von
B. Sigman
D. F. Linder
J. L. Waller
W. B. Bollag
S. L. Baer
S. Tran
M. Kheda
L. Young
A. Mohammed
C. M. Isales
B. Siddiqui
Publikationsdatum
04.04.2023
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 10/2023
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-023-02065-9

Weitere Artikel der Ausgabe 10/2023

Journal of Endocrinological Investigation 10/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.